Physician profile
Justin J Ernat
NPI 1205120177
$181,333.22
in general payments reported to CMS, 2019-2025
10 companies · $35K in 2025
The $35K reported for 2025 was more than what 94% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,251 · 2020: $6,585 · 2021: $45K · 2022: $18K · 2023: $31K · 2024: $37K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $94K · Travel and Lodging: $7,558 · Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $94,331.25 |
| Travel and Lodging | $7,558.28 |
| Food and Beverage | $1,412.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $114,145.74 | 2019-2025 | Rigidloop, Milagro, Monovisc |
| Depuy Synthes Products, INC. | $25,950.54 | 2021-2024 | Rigidloop, Intrafix, Monovisc |
| Arthrex, INC. | $25,078.51 | 2020-2021 | |
| Smith+Nephew, INC. | $12,937.50 | 2020-2021 | |
| Gemini Mountain Medical, LLC | $1,200.00 | 2021 | |
| Stryker Corporation | $1,081.08 | 2025 | Inspace, Salvation, Alphavent |
| Depuy Synthes Sales INC. | $690.62 | 2019-2025 | Healix Knotless Peek, Gryphon Orthocord, Rigidloop |
| Vericel Corporation | $154.68 | 2021 | |
| Active Medical, LLC | $81.41 | 2021 | |
| Bioventus LLC | $13.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Ernat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.